Sun Pharmaceutical Industries share price finishes at ₹1,769.90, down 0.01% on November 3

Anupama VM - 0 min read

Last Updated: 3rd November 2026 - 06:20 pm

Key Takeaways

  • Sun Pharmaceutical Industries ended November 3 at ₹1,769.90, down 0.01%, after opening at ₹1,766 and trading between ₹1,747 and ₹1,785.
  • The close remained below the 50-day DMA of ₹1,814.30 and 200-day DMA of ₹1,814.40, while the reported one-month return was -1.73%.
  • Sun Pharmaceutical Industries recorded 2,710,131 shares in session volume; its one-month and one-year reported returns were -1.73% and 4.68%, respectively.

Sun Pharmaceutical Industries share price declined to ₹1,769.90 on November 3, 2026. That represented a decline of ₹0.1, or 0.01%, on the day. The previous closing quotation was approximately ₹1,770, and the day began at ₹1,766.

The moving-average figures provide three distinct historical reference levels. At the close, Sun Pharmaceutical Industries was ₹44.40 below its 50-day DMA of ₹1,814.30. Its 100-day DMA was ₹1,832.50, putting the final quote ₹62.60 below that level. The 200-day DMA stood at ₹1,814.40, ₹44.50 above the closing price.

The session high was ₹1,785 and the low ₹1,747, a quoted spread of ₹38. Only ₹15.10 separated the close from the day’s high, compared with ₹22.90 from the low. The opening quotation was ₹4 below the rounded previous close. Relative to the open, the closing price finished ₹3.90 above that starting level.

The published 52-week low stood at ₹1,584 and the high at ₹2,047, covering a ₹463 price interval. The November 3 close was ₹185.90 above the rounded annual low and ₹277.10 below the rounded annual high. The day’s ₹38 trading range was smaller than the full-year spread of ₹463.

The one-month return was -1.73%, while the three-month reading was -11.08%. Over six months, the reported return was -2.12%; over one year, it was 4.68%. The six-month and one-year figures differed by 6.80 percentage points, and the one- and three-month figures differed by 9.35 percentage points.

Market capitalisation was approximately ₹424,658 crore. This figure describes the quoted equity valuation on the stock page; it is distinct from the session trading volume of 2,710,131 shares. At ₹1,769.90 per share, the closing quotation was within the annual ₹1,584 to ₹2,047 trading interval.

Trading volume reached 2,710,131 shares. Expressed in millions, that was approximately 2.71 million shares. The session’s highest and lowest quotations were separated by 2.15% of the rounded previous close, while the reported closing-to-closing change was 0.01%. The range and closing change capture separate aspects of the day’s movement.

Across the reported return horizons, the largest numerical return was 4.68% and the lowest was -11.08%. The gap between the two figures was 15.76 percentage points. The figures reflect their respective trailing periods through the stated reporting date.

The session therefore ended at ₹1,769.90, against an opening quotation of ₹1,766 and a previous-close reference of ₹1,770. The daily move, ₹1,747–₹1,785 trading interval, and moving-average positions complete the November 3 post-market price record.

Frequently Asked Questions

What was the Sun Pharmaceutical Industries share price on November 3, 2026? 

How did Sun Pharmaceutical Industries compare with its moving averages? 

What were the recent returns and annual range for Sun Pharmaceutical Industries? 

FREE Trading & Demat Account
Open FREE Demat Account with endless opportunities.
  • Flat ₹20 Brokerage
  • Next-gen Trading
  • Advanced Charting
  • Actionable Ideas
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
OR
hero_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form